It’s easy to test for galactosemia. It’s also simple to treat once it’s diagnosed. And children who have it can live normal lives. Type I occurs in about 1 in every 30,000 to 60,000 people.

The US Food and Drug Administration (FDA) has declined to approve Applied Therapeutics’ govorestat for classic galactosemia, ...

Nearly three months after an experimental treatment for classic galactosemia was rejected by the US Food and Drug ...

Galactosemia is an inherited genetic disorder of metabolism where the body is unable to metabolize a sugar called galactose. Galactose forms half of the sugar lactose, which is found in milk. The ...

Galactosemia is a rare genetic disorder that results from the body’s inability to properly metabolize galactose, converting instead to the toxic metabolite, galactitol, which is known to cause ...

The Applied drug was developed as a treatment for galactosemia, a rare inherited disease that leads to severe deficiency of enzymes needed to metabolize galactose. This sugar is produced by the ...

Substantial upside exists not only in galactosemia, Schwartz wrote, but in the second indication for which govorestat is being developed, the hereditary neuropathy sorbitol dehydrogenase (SORD ...

Galactosemia is a rare genetic disorder that causes an inability to digest galactose, which is a breakdown product of lactose. Lactose is one of the main carbohydrates in milk. In the infant ...